| scholarly article | Q13442814 |
| P50 | author | Carlos Tomaz | Q37381319 |
| P2093 | author name string | Ricardo Bentes Azevedo | |
| Victoria Monge-Fuentes | |||
| Caroline R A Valois | |||
| Maria Clotilde Henriques Tavares | |||
| Emilia C D Lima | |||
| Danilo Simonini Teixeira | |||
| Monica Pereira Garcia | |||
| Paulo C Sar Morais | |||
| P2860 | cites work | Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy | Q21223673 |
| Nanoparticle inhalation augments particle-dependent systemic microvascular dysfunction | Q23922832 | ||
| Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells | Q24539098 | ||
| Renal clearance of quantum dots | Q24657265 | ||
| Sophistications of cell sorting. | Q50640256 | ||
| Interaction of erythrocytes with magnetic nanoparticles. | Q50697817 | ||
| Simultaneous detection of multiple cytokines and chemokines from nonhuman primates using luminex technology | Q50768127 | ||
| Iron oxide nanoparticles for sustained delivery of anticancer agents. | Q51444164 | ||
| Intratumoral injection of immature dendritic cells enhances antitumor effect of hyperthermia using magnetic nanoparticles. | Q51504570 | ||
| Toxicity of Gold Nanoparticles Functionalized with Cationic and Anionic Side Chains | Q56443622 | ||
| In vivo magnetic resonance detection of cancer by using multifunctional magnetic nanocrystals | Q57187703 | ||
| Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system | Q57365250 | ||
| Targeted Intracellular Delivery of Hydrophobic Agents using Mesoporous Hybrid Silica Nanoparticles as Carrier Systems | Q58941015 | ||
| Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications | Q29615464 | ||
| The potential environmental impact of engineered nanomaterials | Q29615518 | ||
| Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol). | Q30729351 | ||
| Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals | Q34188389 | ||
| Cell-specific targeting of nanoparticles by multivalent attachment of small molecules | Q34462201 | ||
| Nanoparticle-based targeted drug delivery | Q35644991 | ||
| Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA. | Q35691719 | ||
| Chemistry and properties of nanocrystals of different shapes. | Q36096252 | ||
| Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats | Q36125194 | ||
| Liver iron transport | Q36177913 | ||
| Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles | Q36319725 | ||
| Interpretation of liver enzymes | Q36750903 | ||
| A toxicologist guide to the diagnostic interpretation of hepatic biochemical parameters | Q36893936 | ||
| Regulation of vascular endothelial cell barrier function and cytoskeleton structure by protein phosphatases of the PPP family | Q36908208 | ||
| Iron overload and immunity | Q36923159 | ||
| Nanoparticles for drug delivery to the lungs | Q36998692 | ||
| Receptor-targeted nanoparticles for in vivo imaging of breast cancer | Q37307237 | ||
| Pharmacokinetics and biodistribution of near-infrared fluorescence polymeric nanoparticles | Q37350964 | ||
| Magnetic resonance imaging of multifunctional pluronic stabilized iron-oxide nanoparticles in tumor-bearing mice | Q37392147 | ||
| Hemochromatosis: Pumping too much iron | Q37498073 | ||
| Iron absorption and metabolism. | Q37520532 | ||
| From iron oxide nanoparticles towards advanced iron-based inorganic materials designed for biomedical applications | Q37665599 | ||
| Dual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapy | Q39741784 | ||
| Targeting to carcinoma cells with chitosan- and starch-coated magnetic nanoparticles for magnetic hyperthermia | Q40015572 | ||
| Linkage of cell-mediated immunity to iron metabolism | Q40422797 | ||
| Nanoscale size effect of magnetic nanocrystals and their utilization for cancer diagnosis via magnetic resonance imaging. | Q40433373 | ||
| Magnetite nanoparticle-loaded anti-HER2 immunoliposomes for combination of antibody therapy with hyperthermia | Q40529070 | ||
| Action of combined magnetic fields on aqueous solution of glutamic acid: the further development of investigations | Q42142725 | ||
| In vivo characterization of renal iron transport in the anaesthetized rat. | Q42624144 | ||
| The effect of DMSA-functionalized magnetic nanoparticles on transendothelial migration of monocytes in the murine lung via a beta2 integrin-dependent pathway. | Q43263100 | ||
| Expression patterns of cell adhesion molecules in mice's lung after administration of meso-2,3-dimercaptosuccinic acid-coated maghemite nanoparticles. | Q46006006 | ||
| Integrated metabolomic analysis of the nano-sized copper particle-induced hepatotoxicity and nephrotoxicity in rats: a rapid in vivo screening method for nanotoxicity | Q46427227 | ||
| Toxicity and tissue distribution of magnetic nanoparticles in mice. | Q46764075 | ||
| Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats. | Q46793159 | ||
| Hematological and plasma biochemical values for captive tufted capuchin monkeys (Cebus apella). | Q46802665 | ||
| Targeting cancer cells: magnetic nanoparticles as drug carriers | Q46919648 | ||
| Perception of the Müller-Lyer illusion in capuchin monkeys (Cebus apella). | Q48128940 | ||
| Synergistically integrated nanoparticles as multimodal probes for nanobiotechnology | Q50624514 | ||
| P433 | issue | 9 | |
| P921 | main subject | nanoparticle | Q61231 |
| magnetite nanoparticle | Q3870166 | ||
| magnetic nanoparticle | Q117817683 | ||
| P304 | page(s) | 1529-1544 | |
| P577 | publication date | 2011-06-15 | |
| P1433 | published in | Nanomedicine | Q15817508 |
| P1476 | title | Biodistribution and biocompatibility of DMSA-stabilized maghemite magnetic nanoparticles in nonhuman primates (Cebus spp.). | |
| P478 | volume | 6 |
| Q55480259 | A Novel Metal-Based Imaging Probe for Targeted Dual-Modality SPECT/MR Imaging of Angiogenesis. |
| Q39261689 | Anti-CEA loaded maghemite nanoparticles as a theragnostic device for colorectal cancer. |
| Q28550277 | Antifungal Activity of Amphotericin B Conjugated to Nanosized Magnetite in the Treatment of Paracoccidioidomycosis |
| Q36687247 | Antitumor effect and toxicity of free rhodium (II) citrate and rhodium (II) citrate-loaded maghemite nanoparticles in mice bearing breast cancer |
| Q90399895 | Aptamers Increase Biocompatibility and Reduce the Toxicity of Magnetic Nanoparticles Used in Biomedicine |
| Q53346868 | Biotransformation of magnetic nanoparticles as a function of coating in a rat model. |
| Q57340519 | Dimercaptosuccinic Acid-Coated Magnetic Nanoparticles as a Localized Delivery System in Cancer Immunotherapy: Tumor Targeting,In VivoDetection and Quantification, Long-term Biodistribution, Biotransformation and Toxicity |
| Q36289257 | In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles |
| Q35838641 | Morphological Analysis of Reticuloendothelial System in Capuchin Monkeys (Sapajus spp.) after Meso-2,3-Dimercaptosuccinic Acid (DMSA) Coated Magnetic Nanoparticles Administration |
| Q47138021 | Multimodality Imaging of Angiogenesis in a Rabbit Atherosclerotic Model by GEBP11 Peptide Targeted Nanoparticles |
| Q34123491 | Perspectives on the application of nanotechnology in photodynamic therapy for the treatment of melanoma |
Search more.